668 related articles for article (PubMed ID: 8780328)
1. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
Singh BN
Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
[TBL] [Abstract][Full Text] [Related]
2. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
3. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
Lazzara R
Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
[TBL] [Abstract][Full Text] [Related]
4. Sotalol: An important new antiarrhythmic.
Anderson JL; Prystowsky EN
Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
[TBL] [Abstract][Full Text] [Related]
5. Choice and chance in drug therapy of cardiac arrhythmias: technique versus drug-specific responses in evaluation of efficacy.
Singh BN
Am J Cardiol; 1993 Nov; 72(16):114F-124F. PubMed ID: 8237824
[TBL] [Abstract][Full Text] [Related]
6. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmias in the intensive care patient.
Trappe HJ; Brandts B; Weismueller P
Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
Steinbeck G; Greene HL
Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
[TBL] [Abstract][Full Text] [Related]
9. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
O'Callaghan PA; McGovern BA
Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
[TBL] [Abstract][Full Text] [Related]
10. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
[TBL] [Abstract][Full Text] [Related]
11. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Anderson JL
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
[TBL] [Abstract][Full Text] [Related]
14. Sotalol: Current Status and Expanding Indications.
Singh BN
J Cardiovasc Pharmacol Ther; 1999 Jan; 4(1):49-65. PubMed ID: 10684524
[TBL] [Abstract][Full Text] [Related]
15. Expanding indications for the use of Class III agents in patients at high risk for sudden death.
Singh BN
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):887-900. PubMed ID: 8548110
[TBL] [Abstract][Full Text] [Related]
16. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone -- waxed and waned and waxed again.
Doggrell SA
Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
[TBL] [Abstract][Full Text] [Related]
19. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Finance O; Manning A; Chatelain P
J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]